A Diacylglycerol Kinase Inhibitor, R-59-022, Blocks Filovirus Internalization in Host Cells

Corina M Stewart1,2,3, Stephanie S Dorion4, Marie A F Ottenbrite5

  • 1Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada. cwark095@uottawa.ca.

Viruses
|March 6, 2019
PubMed

Insights

A diacylglycerol kinase inhibitor, R-59-022, effectively blocks Ebola virus (EBOV) entry into cells by inhibiting macropinocytosis. This finding offers a potential therapeutic strategy against filoviral infections.

Area of Science:

  • Virology
  • Cell Biology
  • Drug Discovery

Background:

  • Filoviruses, including Ebola virus (EBOV) and Marburg virus, cause severe hemorrhagic fevers.
  • Filovirus entry into host cells requires internalization and delivery to intracellular vesicles containing cathepsin proteases and Niemann-Pick C1.
  • EBOV entry is known to involve glycoprotein (GP)-dependent macropinocytosis, but the precise molecular mechanisms remain unclear.

Purpose of the Study:

  • To investigate the molecular events governing filovirus internalization.
  • To identify potential therapeutic targets for filoviral infections.

Main Methods:

  • Utilized the diacylglycerol kinase inhibitor R-59-022 to study EBOV entry.
  • Examined the effect of R-59-022 on viral particle internalization via macropinocytosis in Vero cells and macrophages.
  • Tested R-59-022 against various pathogenic filovirus GPs and replicative EBOV.

Main Results:

  • R-59-022 effectively inhibited EBOV glycoprotein (GP)-mediated entry into Vero cells and macrophages.
  • The inhibitor blocked an early step in viral entry, specifically the internalization of viral particles through macropinocytosis.
  • R-59-022 demonstrated efficacy against a range of filovirus GPs and inhibited the replication of Ebola virus.

Conclusions:

  • Diacylglycerol kinase inhibition by R-59-022 represents a novel strategy to block filovirus entry.
  • R-59-022 can serve as a valuable research tool for studying filovirus macropinocytosis.
  • This inhibitor shows promise as a potential starting point for developing broad-spectrum antiviral therapeutics against filoviruses.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
506
Internal Energy02:00

Internal Energy

The total of all possible kinds of energy present in a substance is called the internal energy (U), sometimes symbolized as E. Suppose a system with initial internal energy, Uinitial, undergoes a change in energy (transfer of work or heat), and the final internal energy of the system is Ufinal. Change in internal energy equals the difference between Ufinal and Uinitial.
36.7K